BO17704 (AVAIL): A PHASE III RANDOMISED STUDY OF FIRST-LINE BEVACIZUMAB COMBINED WITH CISPLATIN/GEMCITABINE (CG) IN PATIENTS (PTS) WITH ADVANCED OR RECURRENT NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
msra（2008）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要